Lasix 250 mg/25 ml inf. sol. (conc.) i.v. amp. 6 x 25 ml
Active ingredient: Furosemide
View notice details →
News topic
Current shortage notices for the ATC group C03CA01, structured by product, country and reporting period.
11 noticesThe 11 consolidated notices from Belgium, Austria, Czechia are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.
Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.
Active ingredient: Furosemide
View notice details →Active ingredient: Furosemide
View notice details →Active ingredient: FUROSEMID
View notice details →Active ingredient: Furosemide
View notice details →Active ingredient: FUROSEMID
View notice details →Active ingredient: FUROSEMID
View notice details →Active ingredient: FUROSEMID
View notice details →Active ingredient: FUROSEMID
View notice details →Active ingredient: FUROSEMID
View notice details →Active ingredient: FUROSEMID
View notice details →Active ingredient: FUROSEMID
View notice details →For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →